Michigan News Updates

Opioid Dependence Market

The Opioid Dependence market growth is driven by factors like increase in the prevalence of Opioid Dependence, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Opioid Dependence market report also offers comprehensive insights into the Opioid Dependence market size, share, Opioid Dependence epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Opioid Dependence market size growth forward. 

Some of the key highlights from the Opioid Dependence Market Insights Report:

• Several key pharmaceutical companies, including Opiant Pharmaceuticals, Orexo, Aphios Pharma, DemeRx IB, Alar Pharmaceuticals, BioXcel Therapeutics, Lyndra Therapeutics, Trevena, Aptinyx, Indivior, Cerevel Therapeutics, BioCorRx, Delpor, AstraZeneca, Gilgamesh Pharmaceuticals, and others, are developing novel products to improve the Opioid Dependence treatment outlook. 
• The total Opioid Dependence market size will include the market size of the potential upcoming therapies and current treatment regimens in the seven major markets.
• As per DelveInsight analysis, the Opioid Dependence market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Opioid Dependence Market Landscape

Opioid Dependence Overview 

Opioid dependence is a disorder of regulation of opioid use arising from repeated or continuous use of opioids. The characteristic feature of dependence is a strong internal drive to use opioids, which manifests itself by an impaired ability to control use, increasing priority given to use over other activities, and persistence in use despite harm or negative consequences.

Opioids can lead to physical dependence within a short time, as little as 4-8 weeks. In other words, the body will become used to opioids so that it has difficulty functioning without them. With chronic use, abruptly stopping opioid use leads to withdrawal symptoms, including generalized pain, chills, cramps, diarrhea, dilated pupils, restlessness, anxiety, nausea, vomiting, insomnia, and very intense cravings. However, people do not die from opioid withdrawal. Because these symptoms are severe, it creates significant motivation to continue using opioids to prevent withdrawal.

Dependence is associated with withdrawal syndrome, which occurs upon cessation of repeated exposure to a drug stimulus. Providers must advise patients not to stop taking chronic opioids without first tapering their medication dosage. Dependence is also a subset of a substance use disorder, manifesting as physical or psychological dependence or both. Opioid withdrawal onset varies with the type of opioid used but correlates with dependence.

Chronic opioid use causes alterations in receptor sensitivity, leading to medication tolerance and changes in pain perception. Opioid-induced hyperalgesia (OIH) causes pain perception out of proportion to the stimulus (hyperalgesia) in those who use or misuse opioids long-term.

Opioids binds to the receptors within the CNS as well as throughout the peripheral tissues. These receptors are normally stimulated by endogenous peptides (endorphins, enkephalins, and dynorphins) produced in response to noxious stimulation. Action on these same receptors induces intense euphoria. This causes many individuals to continue using with the intention of recreating that first high. Most people who misuse opioids do so for pain relief or to prevent withdrawal symptoms.

The development of effective treatments for opioid dependence is of great importance given the devastating consequences of the disease. Counseling and behavioral therapies may be an important part of treatment alongside medications; however, they are effective by themselves. Medications are also used to relieve cravings, relieve withdrawal symptoms, and block the euphoric effects of opioids. These medications do not “cure” the disorder but rather improve safety and prevent withdrawal symptoms, which can lead to relapse or continued drug use.

Do you know the treatment paradigms for different countries? Download our Opioid Dependence Market Sample Report

Opioid Dependence Epidemiology Segmentation 

DelveInsight’s Opioid Dependence market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Opioid Dependence historical patient pools and forecasted Opioid Dependence patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Opioid Dependence Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

• Opioid Dependence Prevalence 
• Age-Specific Opioid Dependence Prevalence 
• Gender-Specific Opioid Dependence Prevalence 
• Diagnosed and Treatable Cases of Opioid Dependence

Visit for more @ Opioid Dependence Epidemiological Insights

Opioid Dependence Treatment Market 

The Opioid Dependence market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Opioid Dependence market trends by analyzing the impact of current Opioid Dependence therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Opioid Dependence market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Opioid Dependence market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Opioid Dependence market in 7MM is expected to witness a major change in the study period 2019-2032.

Opioid Dependence Therapy Assessment

• OX 124: Orexo
• APH-1501: Aphios
• DMX-1002: DemeRx IB
• Noribogaine: DemeRx IB

Opioid Dependence Key Companies

• Opiant Pharmaceuticals
• Orexo
• Aphios Pharma
• DemeRx IB, Inc.
• Alar Pharmaceuticals
• BioXcel Therapeutics
• Lyndra Therapeutics
• Trevena
• Aptinyx
• Indivior
• Cerevel Therapeutics
• BioCorRx
• Delpor
• AstraZeneca
• Gilgamesh Pharmaceuticals

For more information, visit Opioid Dependence Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Opioid Dependence Market Report:

• 11 Years Forecast
• 7MM Coverage 
• Descriptive overview of Opioid Dependence, causes, signs and symptoms, diagnosis, treatment
• Comprehensive insight into Opioid Dependence epidemiology in the 7MM
• Opioid Dependence marketed and emerging therapies 
• Opioid Dependence companies
• Opioid Dependence market drivers and barriers 

Key Questions Answered in the Opioid Dependence Market Report 2032:

• What was the Opioid Dependence market share distribution in 2019, and how would it appear in 2032?
• What is the total Opioid Dependence market size and the market size by therapy across the 7MM for the study period (2019-32)?
• What are the important findings from 7MM, and which country will have the greatest Opioid Dependence market size from 2019-32?
• During the study period (2019-2032), at what CAGR is the Opioid Dependence market projected to expand at 7MM?

Table of Contents:

1 Opioid Dependence Market Key Comprehensive Insights 

2 Opioid Dependence Market Report Introduction

3 Competitive Intelligence Analysis for Opioid Dependence

4 Opioid Dependence Market Analysis Overview at a Glance

5 Executive Summary of Opioid Dependence

6 Opioid Dependence Epidemiology and Market Methodology

7 Opioid Dependence Epidemiology and Patient Population

8 Opioid Dependence Patient Journey

9 Opioid Dependence Treatment Algorithm, Opioid Dependence Current Treatment, and Medical Practices

10 Key Endpoints in Opioid Dependence Clinical Trials

11 Opioid Dependence Marketed Therapies 

12 Opioid Dependence Emerging Therapies

13 Opioid Dependence: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Opioid Dependence

16 Opioid Dependence Market Key Opinion Leaders Reviews

18 Opioid Dependence Market Drivers

19 Opioid Dependence Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Opioid Dependence Epidemiology 2032

DelveInsight’s “Opioid Dependence – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Opioid Dependence epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Opioid Dependence Pipeline 2023

“Opioid Dependence Pipeline Insights, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Opioid Dependence market. A detailed picture of the Opioid Dependence pipeline landscape is provided, which includes the disease overview and Opioid Dependence treatment guidelines. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/